Tag Archives: diabetes

CCHR Int Releases New Psychiatric Drug Search Engine—310 International Drug Regulatory Warnings & Studies & 194,000 Adverse Psychiatric Drug Reaction Reports

Psychiatric drugs sales generate $80 billion per year with Big Pharma spending $4.7 billion per year on TV and print ads, and $1 billion per year on internet advertising.

As a result the number of people worldwide taking psychiatric drugs has skyrocketed to 100 million (20 million of them children) with documented side effects of worsening depression, mania, psychosis, violence, suicidal and homicidal ideation, diabetes, birth defects, heart attack, stroke and sudden death – to name but a few.

International drug regulatory warnings have increased by 400% in the last 10 years, yet the general public has nowhere to go to find this information online in an easy to search, concise format. Until now.

Pharma Funded FDA’s Christmas Present to Drug Companies: Approving use of deadly antipsychotic drugs for kids

Many states have sued over the cost of atypical antipsychotic drugs, especially the cost of treating the diabetes and metabolic disorders they cause, which has decimated Medicaid budgets. Yet now the FDA gives pharma the Christmas present of approving Seroquel and Zyprexa for children and hence, Medicaid reimbursement even as its own Division of Pharmacovigilance (DPV) reported a “a direct association between adverse metabolic effects of treatment with atypical antipsychotics” and children!

FDA ‘considers’ Antipsychotic drug labels warning of weight gain/diabetes. Considers? Do your job-issue the warnings.

A study published last month in the Journal of the American Medical Association found the drugs caused children and adolescents to gain an average of 19 pounds in 11 weeks of treatment. The concern with weight gain seen with most antipsychotic drugs is whether it causes additional problems such as diabetes and cardiovascular disease. A top Food and Drug Administration official said Tuesday the agency is considering strengthening the labels of antipsychotic drugs to warn about weight gain and diabetes amid concerns the impact could be stronger in children compared to adults.